Foundation Medicine Enhances Cancer Care for Veterans
Foundation Medicine, Inc. has made notable progress in its partnership with the U.S. Department of Veterans Affairs (VA), recently securing an important contract to provide essential tumor molecular profiling services to veterans facing cancer. This award highlights a strong commitment to improving cancer care through precision medicine, in line with the VA’s National Precision Oncology Program.
Innovative Tumor Profiling Tests
This contract enables Foundation Medicine to offer a range of advanced diagnostic tests, such as FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme. These tests are specifically designed to pinpoint the genomic mutations that drive cancer, helping doctors recommend the most suitable treatment options. By utilizing cutting-edge molecular profiling, the program guarantees that veterans receive personalized treatment plans tailored to their unique needs.
Commitment to Veterans’ Health
Annie Murphy, Chief Commercial Officer at Foundation Medicine, expressed her pride in continuing this important collaboration with the VA. “It’s essential for us to ensure veterans have access to high-quality diagnostic testing, which is critical for making informed treatment decisions,” she noted. The program's goal is to provide dependable results, allowing healthcare professionals to customize therapies that meet each patient’s requirements.
The Importance of Precision Oncology
By combining tissue-based and liquid biopsy tests, Foundation Medicine empowers healthcare providers to effectively navigate intricate cancer profiles. These tests help in identifying targeted therapies and clinical trials, enhancing treatment outcomes for veterans who deserve exceptional care. This multifaceted approach illustrates how precision oncology personalizes cancer care, ensuring veterans are treated as individuals rather than just statistics.
Historical Context and Ongoing Efforts
Foundation Medicine first partnered with the VA back in 2019, facilitating advanced genomic profiling to support veterans’ health. As the landscape of cancer treatment evolves, Foundation Medicine’s latest contract builds on this commitment, demonstrating the organization’s focus on integrating research with clinical practice. Through continuous innovation, their efforts play a significant role in advancing cancer diagnostics and therapies.
About Foundation Medicine: Pioneering Cancer Care
Foundation Medicine is at the forefront of molecular profiling, actively working to set high standards in cancer diagnostics. The company collaborates with a wide range of stakeholders within the cancer community to elevate the quality of care. With a robust understanding of cancer biology, they inform treatment paths that empower both healthcare professionals and researchers.
By integrating advanced testing methodologies and engaging in vital research initiatives, Foundation Medicine enables healthcare providers to make well-informed decisions regarding patient treatment options. Their commitment is founded on the belief that everyone deserves access to information that can transform cancer care.
Frequently Asked Questions
What services does Foundation Medicine provide to veterans?
Foundation Medicine offers tumor molecular profiling tests to identify the most effective cancer treatment options for veterans.
What is precision oncology?
Precision oncology is a personalized approach to cancer treatment that focuses on identifying specific genomic mutations in a patient’s tumor, directing targeted therapies.
How does FoundationOne CDx contribute to cancer care?
FoundationOne CDx identifies genetic alterations in cancers, assisting healthcare providers in choosing suitable targeted therapies.
Why is tumor profiling important for veterans?
Tumor profiling enables personalized treatment plans that align with the specific genetic characteristics of a veteran’s cancer, leading to better outcomes.
How does Foundation Medicine collaborate with healthcare providers?
Foundation Medicine works with healthcare professionals to provide access to top-tier diagnostic testing and support informed treatment decisions.